Madrigal Pharmaceuticals, Inc.
NASDAQ:MDGL · NASDAQ Global Select
-$1.33 today
Vol 0.49M · Avg 0.31M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+78.72%
Period High
$602.83
Period Low
$277.64
Latest
$505.75
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Moderna, Inc.
NASDAQ:MRNA
$24.52B
Jazz Pharmaceuticals plc
NASDAQ:JAZZ
$14.26B
Exelixis, Inc.
NASDAQ:EXEL
$13.18B
BioMarin Pharmaceutical Inc.
NASDAQ:BMRN
$10.63B
Baxter International Inc.
NYSE:BAX
$10.01B
Bio-Techne Corporation
NASDAQ:TECH
$8.61B
Rhythm Pharmaceuticals, Inc.
NASDAQ:RYTM
$6.57B
Abivax S.A.
NASDAQ:ABVX
$6.57B
Caris Life Sciences, Inc.
NASDAQ:CAI
$5.05B
Atrium Therapeutics, Inc.
NASDAQ:RNA
$213.48M
What is the latest MDGL filing?
The latest filing shown is 8-K dated Jun 17, 2026.
How many recent filings does MDGL have?
Intrinsic Alpha currently shows 20 recent filings for MDGL.
Explore More
Continue the stock analysis
Jump to another research area for this company.